Eli Lilly Signs a License Agreement with Seed Therapeutics for Protein Degradation-Based Therapies
Shots: Seed Therapeutics to receive $10M upfront, $10M equity investment, ~$780M as pre/clinical development, regulatory & commercial milestones along with royalties on net sales of […]